402 related articles for article (PubMed ID: 9613241)
1. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy.
Xiao Z; Miller GG; McCallum TJ; Brown KM; Lown JW; Tulip J; Moore RB
Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241
[TBL] [Abstract][Full Text] [Related]
2. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid.
Chang SC; MacRobert AJ; Bown SG
J Urol; 1996 May; 155(5):1744-8. PubMed ID: 8627876
[TBL] [Abstract][Full Text] [Related]
4. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model.
Iinuma S; Bachor R; Flotte T; Hasan T
J Urol; 1995 Mar; 153(3 Pt 1):802-6. PubMed ID: 7861543
[TBL] [Abstract][Full Text] [Related]
7. Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers.
Xiao Z; Brown K; Tulip J; Moore RB
J Urol; 2003 Jan; 169(1):352-6. PubMed ID: 12478188
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder.
Vandepitte J; Van Cleynenbreugel B; Hettinger K; Van Poppel H; de Witte PA
Cancer Chemother Pharmacol; 2011 Apr; 67(4):775-81. PubMed ID: 20532886
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study.
Chang SC; MacRobert AJ; Porter JB; Bown SG
J Photochem Photobiol B; 1997 Apr; 38(2-3):114-22. PubMed ID: 9203372
[TBL] [Abstract][Full Text] [Related]
10. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
11. The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma.
Grönlund-Pakkanen S; Wahlfors J; Talja M; Kosma VM; Pakkanen TM; Ala-Opas M; Alhava E; Moore RB
BJU Int; 2003 Jul; 92(1):125-30. PubMed ID: 12823396
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
Hua Z; Gibson SL; Foster TH; Hilf R
Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
[TBL] [Abstract][Full Text] [Related]
13. Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate.
Berrahmoune S; Fotinos N; Bezdetnaya L; Lange N; Guedenet JC; Guillemin F; D'Hallewin MA
Photochem Photobiol Sci; 2008 Sep; 7(9):1018-24. PubMed ID: 18754047
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.
Bachor R; Flotte TJ; Scholz M; Dretler S; Hasan T
J Urol; 1992 May; 147(5):1404-10. PubMed ID: 1569696
[TBL] [Abstract][Full Text] [Related]
15. In vivo fluorescence kinetics of porphyrins following intravesical instillation of 5-aminolaevulinic acid in normal and tumour-bearing rat bladders.
Heil P; Stocker S; Sroka R; Baumgartner R
J Photochem Photobiol B; 1997 Apr; 38(2-3):158-63. PubMed ID: 9203377
[TBL] [Abstract][Full Text] [Related]
16. The importance of fluorescence distribution and kinetics of ALA-induced PpIX in the bladder in photodynamic therapy.
Grönlund-Pakkanen S; Mäkinen K; Talja M; Kuusisto A; Alhava E
J Photochem Photobiol B; 1997 Apr; 38(2-3):269-73. PubMed ID: 9203390
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder.
Leveckis J; Burn JL; Brown NJ; Reed MW
J Urol; 1994 Aug; 152(2 Pt 1):550-3. PubMed ID: 8015110
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
19. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
Loh CS; MacRobert AJ; Bedwell J; Regula J; Krasner N; Bown SG
Br J Cancer; 1993 Jul; 68(1):41-51. PubMed ID: 8318419
[TBL] [Abstract][Full Text] [Related]
20. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.
Lange N; Jichlinski P; Zellweger M; Forrer M; Marti A; Guillou L; Kucera P; Wagnières G; van den Bergh H
Br J Cancer; 1999 Apr; 80(1-2):185-93. PubMed ID: 10389995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
